Statins as modulators of bone formation (Q24806116)

5 July 2017

8 references

20 August 2019

2 October 2019

6 October 2019

11 October 2019

20 November 2019

21 July 2020

30 January 2021

26 August 2022

Statins as modulators of bone formation (English)

1 reference

human musculoskeletal system

5 July 2017

main subject

physiological phenomenon

1 reference

20 August 2019

1 reference

2 October 2019

1 reference

6 October 2019

1 reference

11 October 2019

1 reference

20 November 2019

2 references

21 July 2020

30 January 2021

2

Tim D Spector

Tim D

Spector

1 reference

5 July 2017

author name string

Christopher J Edwards

series ordinal

1

author given names

Christopher J

author last names

Edwards

1 reference

5 July 2017

language of work or name

English

0 references

publication date

21 January 2002

10 references

Arthritis Research and Therapy

5 July 2017

20 August 2019

2 October 2019

6 October 2019

11 October 2019

20 November 2019

5 June 2020

21 July 2020

30 January 2021

26 August 2022

1 reference

5 July 2017

8 references

20 August 2019

2 October 2019

6 October 2019

11 October 2019

20 November 2019

21 July 2020

30 January 2021

26 August 2022

4

1 reference

5 July 2017

issue

3

1 reference

5 July 2017

page(s)

151-153

1 reference

Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study

5 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=128924

HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=128924

Effect of pravastatin on frequency of fracture in the LIPID study: secondary analysis of a randomised controlled trial. Long-term Intervention with Pravastatin in Ischaemic Disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=128924

Clinical pharmacokinetics of pravastatin: mechanisms of pharmacokinetic events

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=128924

Simvastatin promotes osteoblast differentiation and mineralization in MC3T3-E1 cells

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=128924

HMG-CoA reductase inhibitors and the risk of fractures

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=128924

Compactin and simvastatin, but not pravastatin, induce bone morphogenetic protein-2 in human osteosarcoma cells

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=128924

Stimulation of bone formation in vitro and in rodents by statins

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=128924

Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=128924

Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=128924

Hydrophilicity/lipophilicity: relevance for the pharmacology and clinical effects of HMG-CoA reductase inhibitors

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=128924

VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=128924

Pitavastatin enhanced BMP-2 and osteocalcin expression by inhibition of Rho-associated kinase in human osteoblasts

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=128924

Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=128924

Use of statins and risk of fractures

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=128924

HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients

28 November 2018

1 reference

12 December 2020

Oral statins and increased bone-mineral density in postmenopausal women

1 reference

12 December 2020

Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials

1 reference

12 December 2020

Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older women

1 reference

12 December 2020

Identifiers

DOI

10.1186/AR399

1 reference

Dimensions Publication ID

5 July 2017

0 references

1 reference

5 July 2017

1 reference